Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

391 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The first Portuguese National Health Examination Survey (2015): design, planning and implementation.
Nunes B, Barreto M, Gil AP, Kislaya I, Namorado S, Antunes L, Gaio V, Santos AJ, Rodrigues AP, Santos J, Roquette R, Alves-Alves C, Castilho E, Cordeiro E, Dinis A, Prokopenko T, Silva AC, Vargas P, Lyshol H, Dias CM. Nunes B, et al. Among authors: rodrigues ap. J Public Health (Oxf). 2019 Sep 30;41(3):511-517. doi: 10.1093/pubmed/fdy150. J Public Health (Oxf). 2019. PMID: 30239797
SARS-CoV-2 Seroprevalence Following a Large-Scale Vaccination Campaign in Portugal: Results of the National Serological Survey, September - November 2021.
Kislaya I, Gonçalves P, Ramalhete S, Barreto M, Torres AR, Gaio V, Gómez V, Manita C, Almeida Santos J, Soeiro S, De Sousa R, Melo A, Henriques C, Guiomar R, Rodrigues AP; ISNCOVID-19 Group. Kislaya I, et al. Among authors: rodrigues ap. Acta Med Port. 2023 Jan 2;36(1):5-14. doi: 10.20344/amp.18528. Epub 2022 Oct 26. Acta Med Port. 2023. PMID: 36288645 Free article.
Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case-case study based on electronic health records.
Kislaya I, Peralta-Santos A, Borges V, Vieira L, Sousa C, Ferreira B, Pelerito A, Gomes JP, Leite PP, Nunes B; PT COVID‐19 group; Machado A, Rodrigues AP, Peixoto VR, Casaca P, Fernandes E, Rodrigues E, Ferreira R, Isidro J, Pinto M, Duarte S, Santos D, Meneses L, Almeida JP, Matias A, Freire S, Grilo T. Kislaya I, et al. Among authors: rodrigues ap, rodrigues e. Influenza Other Respir Viruses. 2023 Mar 14;17(3):e13121. doi: 10.1111/irv.13121. eCollection 2023 Mar. Influenza Other Respir Viruses. 2023. PMID: 36935845 Free PMC article.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Lanièce Delaunay C, Martínez-Baz I, Sève N, Domegan L, Mazagatos C, Buda S, Meijer A, Kislaya I, Pascu C, Carnahan A, Oroszi B, Ilić M, Maurel M, Melo A, Sandonis Martín V, Trobajo-Sanmartín C, Enouf V, McKenna A, Pérez-Gimeno G, Goerlitz L, de Lange M, Rodrigues AP, Lazar M, Latorre-Margalef N, Túri G, Castilla J, Falchi A, Bennett C, Gallardo V, Dürrwald R, Eggink D, Guiomar R, Popescu R, Riess M, Horváth JK, Casado I, García MDC, Hooiveld M, Machado A, Bacci S, Kaczmarek M, Kissling E; European Primary Care Vaccine Effectiveness Group. Lanièce Delaunay C, et al. Among authors: rodrigues ap. Euro Surveill. 2024 Mar;29(13):2300403. doi: 10.2807/1560-7917.ES.2024.29.13.2300403. Euro Surveill. 2024. PMID: 38551095 Free PMC article.
391 results